Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)

Condition:   HIV/HCV CoinfectionIntervention:   Drug: Peginterferon Alfa-2Sponsor:   Hoffmann-La RocheTerminated - verified May 2016

Source: ClinicalTrials.gov - May 3, 2016 Category: Research Source Type: clinical trials